REGN


2 Biotech Giants in the Hunt for New Coronavirus Drugs

With the number of confirmed COVID-19 cases rising despite worldwide lockdowns and social distancing efforts, the biotech industry is taking action. In just two months since …

3 Biotech Stocks Fighting the Coronavirus; Here’s What to Expect

A saying on Wall Street is that the market hates uncertainty, and unfortunately that looks to be playing out in global stock markets …

A Tale of 3 Healthcare Stocks – 2 to Buy, and 1 to Sell

When investment bank Oppenheimer talks, investors listen — or they should. One of the 10 top performing research firms tracked by TipRanks, 61% …

Are These 5 Biotech Stocks About to Get Bought Out?

In a previous article, I talked about the so-called patent cliff and the correlation to the pace of mergers and acquisitions in the pharma …

Dane Leone Fears Regeneron Pharmaceuticals Inc Could Be Facing Big Competition from Roche

After Roche released initially reassuring datasets for its wet AMD and DME candidate, BTIG’s Dane Leone believes this spells trouble for REGN.

Analysts Sidelined Despite Key Strides from Vertex Pharmaceuticals Incorporated (VRTX) and Regeneron Pharmaceuticals Inc (REGN)

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN) have excited investors with key clinical moves forward for the firms, between VRTX’s double …

Regeneron Pharmaceuticals Inc (REGN) and Sanofi (SNY) Win FDA Approval of DUPIXENT

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) and Sanofi (NYSE:SNY) announced that the FDA approved DUPIXENT® (dupilumab) Injection, the first and only biologic medicine approved for …

Company Update (NASDAQ:REGN): Regeneron Pharmaceuticals Inc and Sanofi to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent Injection

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) and Sanofi announced that they will appeal the injunction granted today by the U.S.

Company Update (NASDAQ:REGN): Regeneron Pharmaceuticals Inc Hires Dr. Jay Markowitz as Senior Vice President of Portfolio Management

Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced that Jay Markowitz, M.D.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts